Citation
Busse, Clara E.; Latour, Chase D.; Dejene, Sara Z.; Knittel, Andrea K.; Wood, Mollie E.; Kinlaw, Alan C.; & Dissanayake, Mekhala V. (2023). Incidence of New Outpatient Long-Acting Reversible Contraceptive Insertions among a Commercially Insured, US Population from 2010 to 2020. Contraception: X, 5, 100101. PMCID: PMC10562738Abstract
OBJECTIVES: Characterize new use of long-acting reversible contraceptives (LARCs), highly effective contraceptive methods, in a broad population over time.STUDY DESIGN: We constructed a retrospective cohort of commercially insured individuals aged 15 to 54 years from 2010 to 2020 and estimated monthly incidence of new LARC insertions.
RESULTS: The monthly standardized incidence increased from 6.0 insertions per 10,000 individuals in January 2010 to 14.1 in December 2020, with a dip in insertions after March 2020. Hormonal intrauterine devices were consistently the most inserted LARC; implants were increasingly favored over time.
CONCLUSIONS: LARCs are increasingly popular forms of contraception among commercially insured individuals.
IMPLICATIONS: Given the increasing popularity, ensuring access to LARCs is critical.
URL
http://dx.doi.org/10.1016/j.conx.2023.100101Reference Type
Journal ArticleYear Published
2023Journal Title
Contraception: XAuthor(s)
Busse, Clara E.Latour, Chase D.
Dejene, Sara Z.
Knittel, Andrea K.
Wood, Mollie E.
Kinlaw, Alan C.
Dissanayake, Mekhala V.